| PESUF22 | Evaluating legal obstacles to provider-assisted injection in Ontario's Supervised Consumption Services | Poster exhibition | Availability and access to harm reduction (including OST and NSP) |
| EPE011 | Evaluating the future use of the dapivirine ring: qualitative key informant interviews with Kenyan policymakers, health managers, and HIV advocates | E-poster | Implementation science of scaling up prevention (including PrEP) |
| EPE234 | Evaluating the Gilead COMPASS Initiative: funding and building capacity of non-profit organizations to end the HIV/AIDS epidemic in the US South | E-poster | Approaches and evidence from cross-sectoral programming and financing |
| EPE049 | Evaluating the impact of WHO's Treat-All guideline on disease progression for people living with HIV in Central Africa from cohort data by target trial design and multi-state modeling | E-poster | Implementation science of scaling up HIV treatment |
| EPB036 | Evaluating two tuberculosis preventive therapy treatment modalities in an HIV treatment program: 3HP versus 6H | E-poster | Tuberculosis: Prevention, diagnosis, treatment |
| EPB024 | Evaluation of a rapid multiplex assay based digital screening strategy in Canada: what's the verdict? | E-poster | Diagnostics of co-infections and co-morbidities |
| EPB247 | Evaluation of HIV drug resistance in virally suppressed patients in Cameroon | E-poster | Resistance to ART |
| EPB018 | Evaluation of low-level viraemia detection across three automated HIVVL assays in Johannesburg, South Africa | E-poster | Viral load and CD4 monitoring |
| PEMOE35 | Evaluation of Ritshidze community-led monitoring programme in South Africa | Poster exhibition | Innovative uses of data to strengthen systems and programmes |
| EPB091 | Evaluation of screening algorithms based on HPV testing with partial genotyping for the prevention of cervical cancer among HIV-infected women in resource-limited countries: results of the ANRS 12375 study | E-poster | Malignancies (AIDS and non-AIDS) |